TrademarkOpen
Search / United States / 97604606

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

VIMFLUITY

Allowed — statement of use stage
Fifth Extension - Granted
Used for: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine…
Show more

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 27 Sep 2022
    Application filed
    New Application Entered
  2. 7 Jul 2023
    Assigned to an examining attorney
    Assigned To Examiner
  3. 11 Jul 2023
    Office action issued
    Non-Final Action Written
  4. 14 Sep 2023
    Response to office action filed
    Teas Response To Office Action Received
  5. 21 Sep 2023
    Office action issued
    Non-Final Action Written
  6. 15 Nov 2023
    Response to office action filed
    Teas Response To Office Action Received
  7. 16 Nov 2023
    Approved for publication
    Approved For Pub - Principal Register
  8. 19 Dec 2023
    Published for opposition
    Published For Opposition
  9. 13 Feb 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  10. 31 Jul 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  11. 16 Jan 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  12. 9 Jul 2025
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 54 events
2026-08-22Sou Extension 5 Granted
2026-08-22Notice Of Approval Of Extension Request E-Mailed
2026-08-21Case Assigned To Intent To Use Paralegal
2026-06-29Sou Teas Extension Received
2026-06-29Sou Extension 5 Filed
2026-05-12Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2026-05-12Attorney/Dom.rep.revoked And/Or Appointed
2026-05-12Teas Change Of Correspondence Received
2026-05-12Teas Withdrawal Of Attorney Received-Firm Retains
2026-01-30Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2026-01-30Attorney/Dom.rep.revoked And/Or Appointed
2026-01-30Teas Change Of Correspondence Received
2026-01-30Teas Withdrawal Of Attorney Received-Firm Retains
2025-12-05Notice Of Approval Of Extension Request E-Mailed
2025-12-04Sou Teas Extension Received
2025-12-04Sou Extension 4 Filed
2025-12-04Sou Extension 4 Granted
2025-09-11Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2025-09-11Attorney/Dom.rep.revoked And/Or Appointed
2025-09-11Teas Change Of Correspondence Received
2025-09-11Teas Withdrawal Of Attorney Received-Firm Retains
2025-07-10Notice Of Approval Of Extension Request E-Mailed
2025-07-09Sou Teas Extension Received
2025-07-09Sou Extension 3 Filed
2025-07-09Sou Extension 3 Granted
2025-03-04Notice Of Approval Of Extension Request E-Mailed
2025-01-16Sou Teas Extension Received
2025-01-16Sou Extension 2 Filed
2025-01-16Sou Extension 2 Granted
2024-07-31Sou Teas Extension Received
2024-07-31Sou Extension 1 Filed
2024-07-31Sou Extension 1 Granted
2024-07-31Notice Of Approval Of Extension Request E-Mailed
2024-02-13Noa Mailed - Sou Required From Applicant
2023-12-19Published For Opposition
2023-12-19Official Gazette Publication Confirmation E-Mailed
2023-11-29Notification Of Notice Of Publication E-Mailed
2023-11-16Approved For Pub - Principal Register
2023-11-15Teas Response To Office Action Received
2023-11-15Correspondence Received In Law Office
2023-11-15Teas/Email Correspondence Entered
2023-09-21Correspondence Received In Law Office
2023-09-21Teas/Email Correspondence Entered
2023-09-21Non-Final Action Written
2023-09-21Non-Final Action E-Mailed
2023-09-21Notification Of Non-Final Action E-Mailed
2023-09-14Teas Response To Office Action Received
2023-07-11Non-Final Action Written
2023-07-11Non-Final Action E-Mailed
2023-07-11Notification Of Non-Final Action E-Mailed
2023-07-07Assigned To Examiner
2023-03-28Teas Voluntary Amendment Received
2022-10-11New Application Office Supplied Data Entered
2022-09-27New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 22 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.